Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

LSE:IMM Stock Jumps 17.03%: Kapiglucagon Development Accelerates as Investors Watch Diabetes Opportunity

ImmuPharma PLC has become one of the notable healthcare movers on 25 August 2026, with LSE:IMM rising 17.03%.

Ankur Sharma | 25 August 2026

Verici Dx Shares Rally 11.11%: Investors Watch Commercialisation and Clinical Diagnostics Growth

Verici Dx plc has become one of the more closely watched small-cap healthcare stocks as investors increasingly assess its transition from a diagnostics developer into a commercially active healthcare business.

Ankur Sharma | 25 August 2026

Solvonis Therapeutics Stock Under Pressure: Phase 3 AUD Trial and New Funding in Focus

Solvonis Therapeutics has become a major small-cap healthcare stock to watch on25 August 2026 after LSE:SVNS declined 10.71%.

Ankur Sharma | 25 August 2026

Shield Therapeutics Falls — Is the Iron-Deficiency Drug Growth Story Facing a Fresh Test?

Shield Therapeutics (LSE:STX), the AIM-listed specialty pharmaceutical company behind the oral iron-deficiency treatment ACCRUFeR, fell 3.09% to 4.70p on 24 August 2026, according to market data. The decline came onVolumeof 1.43 million shares, a relative volume of 0.54, leaving the company with aMarket Capitalisationof …

Ankur Sharma | 25 August 2026

Poolbeg Pharma Slides — Is This Biotech Pullback a Warning or an Opportunity?

Poolbeg Pharma (LSE:POLB), the Dublin-headquartered clinical-stage biotech listed on AIM, fell 3.41% to 8.50p on 24 August 2026, according to available market data of the day's UK biggest losers, onVolumeof 3.09 million shares against a relative volume of 1.08 — close to the stock's …

Ankur Sharma | 25 August 2026

Oxford Biomedica Drops — Is the Cell-and-Gene Therapy Recovery Still Intact?

Oxford BioMedica (LSE:OXB), the Oxford-based cell and gene therapy contract development and manufacturing organisation (CDMO), fell 3.23% to 509p on 24 August 2026, putting it among the day's biggest London-listed decliners per available market data. The stock carries no meaningful trailing price/earnings ratio — …

Ankur Sharma | 25 August 2026

ImmuPharma Slides Despite Kapiglucagon Progress — Is the Market Missing the Kymos Catalyst?

Shares in ImmuPharma plc (LSE:IMM), the AIM-listed biopharmaceutical company developing treatments for autoimmune disease and diabetes, fell 14.66% to 3.405p on 24 August 2026, according to the market-data provider’s "Biggest losers in the United Kingdom" snapshot, onVolumeof 1.37 million shares. The fall values the …

Ankur Sharma | 25 August 2026

ProBiotix Drops Despite a Profit Turnaround — Why Are Investors Selling After Strong H1 Growth?

Shares in Probiotix Health Plc (LSE:PBX), the cholesterol-lowering and cardiometabolic supplement ingredientsBusinessspun out of OptiBiotix Health, fell 14.57% to 9.35p on 24 August 2026, according to the the market-data provider’s "Biggest losers in the United Kingdom" snapshot, on volume of 10,050 shares. The move …

Ankur Sharma | 25 August 2026

LSE:HLN Shares Gain 1.85% as Margin Expansion and Strong Emerging Markets Boost Investor Interest

Haleon shares rose1.85% on 24 August 2026, closing at approximately369.80p. The gain came as investors continued to digest the company's first-half results and assess whether improving margins can compensate for relatively modest top-line growth.

Ankur Sharma | 25 August 2026

LSE:PSON Rallies 2.47%: Can Pearson Sustain Its Digital Education Growth

Pearson shares rose2.47% on 24 August 2026, closing at around1,225p. The move came after the company had already attracted significant investor attention following its strong first-half performance and continued progress in digital education.

Ankur Sharma | 25 August 2026
Support

Hi! How can we help you today?

Loading…